Bristol Myers and Johnson & Johnson ended the Librexia ACS trial after an interim review showed low efficacy, while AF and ...

Flying puts significant strain on your cardiovascular system due to reduced cabin pressure, lower oxygen levels, and dry air.

Bristol Myers Squibb and Johnson & Johnson to discontinue phase 3 Librexia ACS trial of milvexian treat acute coronary syndrome: Princeton, New Jersey Monday, November 17, 2025, 1 ...

LDL cholesterol level < 40 vs ≥ 70 mg/dL is linked to lower rates of future major cardiovascular events in patients with ...

Stepping into an aircraft often feels like a smooth transition from ground to sky. Frequent flyers especially tend to believe they are simply sitting back and relaxing until the plane touches down.

Chair exercises and seated aerobics are ideal for frail beginners or those with balance problems. Try seated marches, arm ...

Silent heart attacks may have mild or no noticeable symptoms, increasing the risk of future complications. Therefore, understanding the warning signs can help.

In TUXEDO-2, ticagrelor failed to meet the bar for noninferiority, with most outcomes hinting at an advantage for prasugrel.

The Librexia clinical trial program includes two other Phase 3 trials, Librexia AF for patients with atrial fibrillation (AF) and Librexia STROKE for secondary stroke prevention (SSP). The IDMC ...

New research from Intermountain Health in Salt Lake City finds that patients diagnosed with peripheral arterial disease (PAD) ...

Shares of Bristol Myers Squibb slumped Friday after the company scrapped a study testing a treatment for acute coronary ...